Brief: Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA Recall
09/05/2024 13:09
May 9 (Reuters) - Lucid Diagnostics Inc LUCD.O :
* LEGACY SPONGE-ON-A-STRING ESOPHAGEAL CELL COLLECTION
DEVICE
SUBJECT OF CLASS II FDA RECALL
* LUCID DIAGNOSTICS INC - ESOPHACAP DEVICE RECALLED DUE TO
RECENT
PUBLICATION OF SERIOUS DEVICE FAILURES
Source text for Eikon: ID:nPn2N47dba
Further company coverage: LUCD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lucid Diagnostics
See all newsBrief: Lucid Diagnostics Begins Receiving Medicare Reimbursement For Esoguard® And Closes $15 Million Financing
Lucid Diagnostics Inc reports results for the quarter ended June 30 - Earnings Summary
Lucid Diagnostics Inc expected to post a loss of 7 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE- Lululemon, United Rentals, cannabis stocks
U.S. STOCKS ON THE MOVE- American Airlines, Pot stocks, Paramount Skydance